194 related articles for article (PubMed ID: 20077047)
1. Comparison between multislice CT and MR imaging in the diagnostic evaluation of patients with pancreatic masses.
Fusari M; Maurea S; Imbriaco M; Mollica C; Avitabile G; Soscia F; Camera L; Salvatore M
Radiol Med; 2010 Apr; 115(3):453-66. PubMed ID: 20077047
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis.
Song SJ; Lee JM; Kim YJ; Kim SH; Lee JY; Han JK; Choi BI
J Magn Reson Imaging; 2007 Jul; 26(1):86-93. PubMed ID: 17659551
[TBL] [Abstract][Full Text] [Related]
3. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and staging of pancreatic carcinoma: MRI versus multislice-CT -- a prospective study].
Grenacher L; Klauss M; Dukic L; Delorme S; Knaebel HP; Düx M; Kauczor HU; Büchler MW; Kauffmann GW; Richter GM
Rofo; 2004 Nov; 176(11):1624-33. PubMed ID: 15497081
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing benign from malignant intraductal papillary mucinous tumors of the pancreas by imaging techniques.
Baba T; Yamaguchi T; Ishihara T; Kobayashi A; Oshima T; Sakaue N; Kato K; Ebara M; Saisho H
Pancreas; 2004 Oct; 29(3):212-7. PubMed ID: 15367887
[TBL] [Abstract][Full Text] [Related]
6. Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability.
Vullierme MP; Giraud-Cohen M; Hammel P; Sauvanet A; Couvelard A; O'Toole D; Levy P; Ruszniewski P; Vilgrain V
Radiology; 2007 Nov; 245(2):483-90. PubMed ID: 17848678
[TBL] [Abstract][Full Text] [Related]
7. Xanthogranulomatous pancreatitis associated with intraductal papillary mucinous tumor.
Kamitani T; Nishimiya M; Takahashi N; Shida Y; Hasuo K; Koizuka H
AJR Am J Roentgenol; 2005 Sep; 185(3):704-7. PubMed ID: 16120922
[No Abstract] [Full Text] [Related]
8. Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography.
Kang HJ; Lee JM; Joo I; Hur BY; Jeon JH; Jang JY; Lee K; Ryu JK; Han JK; Choi BI
Radiology; 2016 Apr; 279(1):128-39. PubMed ID: 26517448
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
[TBL] [Abstract][Full Text] [Related]
10. Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.
Walter TC; Steffen IG; Stelter LH; Maurer MH; Bahra M; Faber W; Klein F; Bläker H; Hamm B; Denecke T; Grieser C
Eur Radiol; 2015 May; 25(5):1329-38. PubMed ID: 25433414
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of incidentally identified pancreatic masses.
Fitzgerald TL; Smith AJ; Ryan M; Atri M; Wright FC; Law CH; Hanna SS
Can J Surg; 2003 Dec; 46(6):413-8. PubMed ID: 14680347
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
13. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
[TBL] [Abstract][Full Text] [Related]
14. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
15. Intraductal papillary mucinous neoplasms with associated invasive carcinoma of the pancreas: imaging findings and diagnostic performance of MDCT for prediction of prognostic factors.
Kim JH; Eun HW; Kim KW; Lee JY; Lee JM; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):565-72. PubMed ID: 23971447
[TBL] [Abstract][Full Text] [Related]
16. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings.
Pilleul F; Rochette A; Partensky C; Scoazec JY; Bernard P; Valette PJ
J Magn Reson Imaging; 2005 Mar; 21(3):237-44. PubMed ID: 15723374
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of positron emission tomography (PET)/contrast-enhanced computed tomography (CE-CT) in discriminating between malignant and benign intraductal papillary mucinous neoplasms (IPMNs).
Ohta K; Tanada M; Sugawara Y; Teramoto N; Iguchi H
Pancreatology; 2017; 17(6):911-919. PubMed ID: 29033011
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease.
McNicholas BA; Kotaro Y; Martin W; Sharma A; Kamath PS; Edwards ME; Kremers WK; Chari ST; Torres VE; Harris PC; Takahashi N; Hogan MC
Pancreas; 2019; 48(5):698-705. PubMed ID: 31091218
[TBL] [Abstract][Full Text] [Related]
19. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
[TBL] [Abstract][Full Text] [Related]
20. Etiologic Distribution of Pancreatic Cystic Lesions Identified on Computed Tomography/Magnetic Resonance Imaging.
Munigala S; Javia SB; Agarwal B
Pancreas; 2019 Sep; 48(8):1092-1097. PubMed ID: 31404022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
